Search research articles
Contact Us
Filters
Showing results (1-10 of 209) with videos related to
Page
of 21
Sort By:
International Review of Psychiatry (Abingdon, England)
|
October 25, 2013
Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment
Helge Frieling, André Tadić
Expert Opinion on Pharmacotherapy
|
January 4, 2019
Pharmacotherapeutic options for co-morbid depression and alcohol dependence
Thomas Hillemacher, Helge Frieling
European Archives of Psychiatry and Clinical Neuroscience
|
August 24, 2006
Tranylcypromine: new perspectives on an "old" drug
Helge Frieling, Stefan Bleich
Pharmacology
|
May 18, 2022
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2
Franziska Bracke, Helge Frieling, Andreas Leffler
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 9, 2018
Link between depression and cardiovascular diseases due to epigenomics and proteomics: Focus on energy metabolism
Kai G Kahl, Britta Stapel, Helge Frieling
BMC Research Notes
|
November 4, 2017
Limitations of lymphoblastoid cell lines for functional analysis of SNPs
Hansi Pathak, Helge Frieling, Mathias Rhein, et al.
Current Opinion in Psychiatry
|
July 21, 2010
Epigenetics and depression: current challenges and new therapeutic options
Marc Schroeder, Marie O Krebs, Stefan Bleich, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 30, 2018
Alcohol, microbiome, and their effect on psychiatric disorders
Thomas Hillemacher, Oliver Bachmann, Kai G Kahl, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 19, 2018
Psychopharmacology in transplantation medicine
Kai G Kahl, Gabriel Eckermann, Helge Frieling, et al.
Der Nervenarzt
|
October 1, 2020
[Antipsychotics during pregnancy: a systematic review]
Thomas Hillemacher, Susanne Simen, Marie-Kathrin Rehme, et al.
Page
of 21
Search research articles
Search
Showing results (1-10 of 209) with videos related to
Sort By:
Page
of 21
International Review of Psychiatry (Abingdon, England)
|
October 25, 2013
Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment
Helge Frieling, André Tadić
Expert Opinion on Pharmacotherapy
|
January 4, 2019
Pharmacotherapeutic options for co-morbid depression and alcohol dependence
Thomas Hillemacher, Helge Frieling
European Archives of Psychiatry and Clinical Neuroscience
|
August 24, 2006
Tranylcypromine: new perspectives on an "old" drug
Helge Frieling, Stefan Bleich
Pharmacology
|
May 18, 2022
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2
Franziska Bracke, Helge Frieling, Andreas Leffler
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 9, 2018
Link between depression and cardiovascular diseases due to epigenomics and proteomics: Focus on energy metabolism
Kai G Kahl, Britta Stapel, Helge Frieling
BMC Research Notes
|
November 4, 2017
Limitations of lymphoblastoid cell lines for functional analysis of SNPs
Hansi Pathak, Helge Frieling, Mathias Rhein, et al.
Current Opinion in Psychiatry
|
July 21, 2010
Epigenetics and depression: current challenges and new therapeutic options
Marc Schroeder, Marie O Krebs, Stefan Bleich, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 30, 2018
Alcohol, microbiome, and their effect on psychiatric disorders
Thomas Hillemacher, Oliver Bachmann, Kai G Kahl, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 19, 2018
Psychopharmacology in transplantation medicine
Kai G Kahl, Gabriel Eckermann, Helge Frieling, et al.
Der Nervenarzt
|
October 1, 2020
[Antipsychotics during pregnancy: a systematic review]
Thomas Hillemacher, Susanne Simen, Marie-Kathrin Rehme, et al.
Page
of 21